0001437749-23-011641.txt : 20230428 0001437749-23-011641.hdr.sgml : 20230428 20230428163021 ACCESSION NUMBER: 0001437749-23-011641 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230428 DATE AS OF CHANGE: 20230428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001833214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 853899721 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39871 FILM NUMBER: 23867013 BUSINESS ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 BUSINESS PHONE: 605-679-6980 MAIL ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 FORMER COMPANY: FORMER CONFORMED NAME: Big Cypress Acquisition Corp. DATE OF NAME CHANGE: 20201120 10-K/A 1 sabs20221231_10ka.htm FORM 10-K/A sabs20221231_10ka.htm
true 0001833214 0001833214 2022-12-31 2022-12-31 0001833214 sabs:CommonStock00001ParValuePerShareCustomMember 2022-12-31 2022-12-31 0001833214 sabs:WarrantsCustomMember 2022-12-31 2022-12-31 0001833214 2022-06-30 0001833214 2023-03-28 iso4217:USD xbrli:shares
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-K/A
(Amendment No. 1)
 
(Mark One) 
 
☒
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 
 
For the fiscal year ended December 31, 2022
--12-31FY2021
 
OR 
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM                   TO 
 
Commission File Number 001-39871
 
SAB BIOTHERAPEUTICS, INC.
(Exact name of Registrant as specified in its Charter)
 
Delaware
85-3899721
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
   
2100 East 54th Street North
Sioux Falls, South Dakota
57104
(Address of principal executive offices)
(Zip Code)
 
Registrant’s telephone number, including area code: (605) 679-6980
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading
Symbol(s)
  
Name of each exchange on which registered
Common stock, $0.0001 par value per share
  
SABS
  
The Nasdaq Stock Market LLC
Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
  
SABSW
  
The Nasdaq Stock Market LLC
 
Securities registered pursuant to Section 12(g) of the Act: None
 
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒
 
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No ☒
 
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
 
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
☐
Accelerated filer
☐
Non-accelerated filer
☒
Smaller reporting company
☒
   
Emerging growth company
☒
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
 
The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant, based on the closing price of the shares of common stock on The Nasdaq Stock Market on June 30, 2022, was $32,737,282.
 
The number of shares of the registrant’s common stock outstanding as of March 28, 2023 was 50,397,762.
 
DOCUMENTS INCORPORATED BY REFERENCE
 
Portions of the registrant’s proxy statement for the 2022 annual meeting of stockholders to be filed pursuant to Regulation 14A within 120 days after the registrant’s fiscal year ended December 31, 2021, are incorporated by reference in Part III of this Form 10-K.
 
Auditor Firm Id:
199
Auditor Name: 
Mayer Hoffman McCann P.C.
Auditor Location:
San Diego, California, United States
 
 
 
 
 
Explanatory Note
 
The purpose of this Amendment No. 1 to the Annual Report on Form 10-K (the “Amendment”) is to amend the cover page of the Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission (the “SEC”) on April 14, 2023, to reflect the correct aggregate market value of the voting and non-voting common equity held by non-affiliates of SAB Biotherapeutics, Inc. (the “Company”), as of June 30, 2022.
 
Except as described above, no other changes have been made to the Annual Report and this Amendment does not reflect events occurring after the filing of the Annual Report, and no attempt has been made in this Amendment to modify or update other disclosures as presented in the Annual Report.
 
Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), this Amendment also contains new certifications of the Company’s principal executive officer and principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Because no financial statements are included in this Amendment and this Amendment does not contain or amend any disclosure with respect to Items 307 or 308 of Regulation S-K promulgated by the SEC under the Exchange Act, paragraphs 3, 4 and 5 of the Section 302 certifications have been omitted. In addition, because no financial statements are included in this Amendment, new certifications of the Company’s principal executive officers and principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 are not required to be included with this Amendment. This Amendment also contains an updated consent of the Company’s independent registered public accounting firm, included as Exhibit 23.1.
 
 
 
 
PART IV
 
Item 15. Exhibits, Financial Statement Schedules
 
 
 
 Exhibit Number
 Description
23.1* Consent of Independent Registered Public Accounting Firm, Mayer Hoffman McCann P.C. 
31.1*
31.2*
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
* Filed herewith.
 
Table of Contents
 
SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
SAB BIOTHERAPEUTICS, INC.
 
 
 
 
Date:
 April 28, 2023
 
By:
/s/ Eddie J. Sullivan
 
 
 
Eddie J. Sullivan
 
 
 
Chief Executive Officer
(Principal Executive Officer)
 
 
 
 
 
 
 
Date:
 April 28, 2023
 
By:
 /s/ Russell Beyer
 
 
 
 Russell Beyer
 
 
 
Chief Financial Officer
(Principal Financial and Accounting Officer)
 
 EX-23.1 2 ex_508389.htm EXHIBIT 23.1 ex_508389.htm

Exhibit 23.1

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in Registration Statement on Form S-8 (File No. 333-262452) and Form S-3 (File No. 333-269565) of our report dated April 14, 2023, relating to the consolidated financial statements of SAB Biotherapeutics, Inc. and Subsidiaries as of December 31, 2022 and 2021 and for each of the two years in the period ended December 31, 2022, included in this Annual Report on Form 10-K for the year ended December 31, 2022.

 

 

/s/ Mayer Hoffman McCann P.C.

 

San Diego, California

April 28, 2023

 

 

 
 EX-31.1 3 ex_502109.htm EXHIBIT 31.1 ex_502109.htm

Exhibit 31.1

 

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Eddie J. Sullivan, certify that:

 

1.

I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of SAB Biotherapeutics, Inc.; and

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

 

         

Date: April 28,2023

       /s/ Eddie J. Sullivan
        Eddie J. Sullivan
       

Chief Executive Officer

(Principal Executive Officer)

 

 
 EX-31.2 4 ex_502110.htm EXHIBIT 31.2 ex_502110.htm

Exhibit 31.2

 

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

 

I, Russell Beyer, certify that:

 

1.

I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of SAB Biotherapeutics, Inc.; and

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

 

         

Date: April 28, 2023

       /s/ Russell Beyer
        Russell Beyer
       

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 
 EX-101.SCH 5 sabs-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 6 sabs-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 7 sabs-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Annual Report Document, Period End Date Current Fiscal Year End Date Document, Fiscal Period Focus Document, Fiscal Year Focus Document, Transition Report Entity, File Number Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Well-known Seasoned Issuer Entity, Voluntary Filers Entity, Current Reporting Status Entity, Interactive Data, Current Entity, Filer Category Entity, Small Business Entity, Emerging Growth Company Entity, Ex Transition Period ICFR Auditor Attestation Flag Entity, Shell Company Entity, Public Float Entity, Common Stock Shares, Outstanding Auditor Firm ID Auditor Name Auditor Location Amendment Description Amendment Flag Entity, Central Index Key Class of Stock [Axis] Class of Stock [Domain] CommonStock00001ParValuePerShare Custom [Member] Warrants Custom [Member] EX-101.PRE 8 sabs-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 9 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document And Entity Information - USD ($)
Dec. 31, 2022
Mar. 28, 2023
Jun. 30, 2022
Document Information [Line Items]      
Entity, Registrant Name SAB BIOTHERAPEUTICS, INC.    
Document, Type 10-K/A    
Document, Annual Report true    
Document, Period End Date Dec. 31, 2022    
Current Fiscal Year End Date --12-31    
Document, Fiscal Period Focus FY    
Document, Fiscal Year Focus 2021    
Document, Transition Report false    
Entity, File Number 001-39871    
Entity, Incorporation, State or Country Code DE    
Entity, Tax Identification Number 85-3899721    
Entity, Address, Address Line One 2100 East 54th Street North    
Entity, Address, City or Town Sioux Falls    
Entity, Address, State or Province SD    
Entity, Address, Postal Zip Code 57104    
City Area Code 605    
Local Phone Number 679-6980    
Entity, Well-known Seasoned Issuer No    
Entity, Voluntary Filers No    
Entity, Current Reporting Status Yes    
Entity, Interactive Data, Current Yes    
Entity, Filer Category Non-accelerated Filer    
Entity, Small Business true    
Entity, Emerging Growth Company true    
Entity, Ex Transition Period false    
ICFR Auditor Attestation Flag false    
Entity, Shell Company false    
Entity, Public Float     $ 32,737,282
Entity, Common Stock Shares, Outstanding   50,397,762  
Auditor Firm ID 199    
Auditor Name Mayer Hoffman McCann P.C.    
Auditor Location San Diego, California, United States    
Amendment Description The purpose of this Amendment No. 1 to the Annual Report on Form 10-K (the “Amendment”) is to amend the cover page of the Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission (the “SEC”) on April 14, 2023, to reflect the correct aggregate market value of the voting and non-voting common equity held by non-affiliates of SAB Biotherapeutics, Inc. (the “Company”), as of June 30, 2022.   Except as described above, no other changes have been made to the Annual Report and this Amendment does not reflect events occurring after the filing of the Annual Report, and no attempt has been made in this Amendment to modify or update other disclosures as presented in the Annual Report.   Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), this Amendment also contains new certifications of the Company’s principal executive officer and principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Because no financial statements are included in this Amendment and this Amendment does not contain or amend any disclosure with respect to Items 307 or 308 of Regulation S-K promulgated by the SEC under the Exchange Act, paragraphs 3, 4 and 5 of the Section 302 certifications have been omitted. In addition, because no financial statements are included in this Amendment, new certifications of the Company’s principal executive officers and principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 are not required to be included with this Amendment. This Amendment also contains an updated consent of the Company’s independent registered public accounting firm, included as Exhibit 23.1.    
Amendment Flag true    
Entity, Central Index Key 0001833214    
CommonStock00001ParValuePerShare Custom [Member]      
Document Information [Line Items]      
Title of 12(b) Security Common stock, $0.0001 par value per share    
Trading Symbol SABS    
Security Exchange Name NASDAQ    
Warrants Custom [Member]      
Document Information [Line Items]      
Title of 12(b) Security Warrants    
Trading Symbol SABSW    
Security Exchange Name NASDAQ    
XML 10 sabs20221231_10ka_htm.xml IDEA: XBRL DOCUMENT 0001833214 2022-12-31 2022-12-31 0001833214 sabs:CommonStock00001ParValuePerShareCustomMember 2022-12-31 2022-12-31 0001833214 sabs:WarrantsCustomMember 2022-12-31 2022-12-31 0001833214 2022-06-30 0001833214 2023-03-28 iso4217:USD shares true 0001833214 10-K/A true 2022-12-31 --12-31 FY 2021 false 001-39871 SAB BIOTHERAPEUTICS, INC. DE 85-3899721 2100 East 54th Street North Sioux Falls SD 57104 605 679-6980 Common stock, $0.0001 par value per share SABS NASDAQ Warrants SABSW NASDAQ No No Yes Yes Non-accelerated Filer true true false false false 32737282 50397762 199 Mayer Hoffman McCann P.C. San Diego, California, United States The purpose of this Amendment No. 1 to the Annual Report on Form 10-K (the “Amendment”) is to amend the cover page of the Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the Securities and Exchange Commission (the “SEC”) on April 14, 2023, to reflect the correct aggregate market value of the voting and non-voting common equity held by non-affiliates of SAB Biotherapeutics, Inc. (the “Company”), as of June 30, 2022.   Except as described above, no other changes have been made to the Annual Report and this Amendment does not reflect events occurring after the filing of the Annual Report, and no attempt has been made in this Amendment to modify or update other disclosures as presented in the Annual Report.   Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), this Amendment also contains new certifications of the Company’s principal executive officer and principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Because no financial statements are included in this Amendment and this Amendment does not contain or amend any disclosure with respect to Items 307 or 308 of Regulation S-K promulgated by the SEC under the Exchange Act, paragraphs 3, 4 and 5 of the Section 302 certifications have been omitted. In addition, because no financial statements are included in this Amendment, new certifications of the Company’s principal executive officers and principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 are not required to be included with this Amendment. This Amendment also contains an updated consent of the Company’s independent registered public accounting firm, included as Exhibit 23.1. EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 5 38 1 false 2 0 false 2 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.sabs.com/20221231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports sabs20221231_10ka.htm ex_502109.htm ex_502110.htm ex_508389.htm sabs-20221231.xsd sabs-20221231_def.xml sabs-20221231_lab.xml sabs-20221231_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "sabs20221231_10ka.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2021q4": 41 }, "contextCount": 5, "dts": { "definitionLink": { "local": [ "sabs-20221231_def.xml" ] }, "inline": { "local": [ "sabs20221231_10ka.htm" ] }, "labelLink": { "local": [ "sabs-20221231_lab.xml" ] }, "presentationLink": { "local": [ "sabs-20221231_pre.xml" ] }, "schema": { "local": [ "sabs-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 46, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 38, "memberCustom": 2, "memberStandard": 0, "nsprefix": "sabs", "nsuri": "http://www.sabs.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "sabs20221231_10ka.htm", "contextRef": "d202310KA", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.sabs.com/20221231/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "sabs20221231_10ka.htm", "contextRef": "d202310KA", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r3", "r4", "r5" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r3", "r4", "r5" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r3", "r4", "r5" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r3", "r4", "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document, Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document, Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document, Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document, Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document, Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document, Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity, Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity, Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity, Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity, Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity, Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity, Common Stock Shares, Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity, Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity, Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity, Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity, File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity, Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity, Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity, Interactive Data, Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity, Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity, Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity, Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity, Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity, Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity, Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity, Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r3", "r4", "r5" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "tradingSymbolItemType" }, "sabs_CommonStock00001ParValuePerShareCustomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CommonStock00001ParValuePerShare Custom [Member]" } } }, "localname": "CommonStock00001ParValuePerShareCustomMember", "nsuri": "http://www.sabs.com/20221231", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "sabs_WarrantsCustomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Custom [Member]" } } }, "localname": "WarrantsCustomMember", "nsuri": "http://www.sabs.com/20221231", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.sabs.com/20221231/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" } }, "unitCount": 2 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 17 0001437749-23-011641-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-23-011641-xbrl.zip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�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end